After generating 23% year-over-year organic growth in a record FY24 Q2, our revenues declined by 7.4% year-over-year, which was in line with our expectations as the contribution from Vapor Power and ...
The company’s EBITDA for the quarter stood at Rs 18,236 crore for the second quarter, with an impressive margin of 53.8%, indicating solid operational efficiency despite lower revenues. However, ...
The annual U.N. climate summit began with some prominent leaders planning to skip the event ahead of tough talks on finance and trade, after a year of weather disasters that have emboldened developing ...
Q3 2024 Earnings Call Transcript November 8, 2024 ANI Pharmaceuticals, Inc. beats earnings expectations. Reported EPS is $1.34, expectations were $1.09. Operator: Good day, everyone, and welcome to ...
7. Council members responded favorably at their Nov. 4 meeting to about a dozen of the program and service fees included in a “Menu of Options” for raising needed revenues suggested by staff. The ...